A carregar...
Anti-IL17A in Axial Spondyloarthritis—Where Are We At?
Knowledge regarding the mechanisms of the IL17–IL23 pathway and its role in spondyloarthritis (SpA) has been pivotal to the development of IL-17 blockade in patients with axial SpA. Previously, only anti-TNF has proven to be clinically efficacious in patients with active disease, despite non-steroid...
Na minha lista:
| Publicado no: | Front Med (Lausanne) |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5241317/ https://ncbi.nlm.nih.gov/pubmed/28149838 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2017.00001 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|